China-based biopharmaceutical firm AffaMed Therapeutics has established its digital medicines subsidiary, AffaMed Digital.
Based on a press release, the newly formed unit will focus on developing and marketing evidence-based, clinically validated digital medicines to treat, diagnose, prevent and manage medical disorders or diseases, either as stand-alone novel treatment options or alongside...
